Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-invasive Airway Epithelial Permeability Measurement in Asthma
NCT02306473Phase 1Completed
- Sponsor
- University of Rochester
- Start
- Oct 2015
- Primary completion
- Dec 2017
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of Bronchitol in asthma (2 arms), sponsored by University of Rochester. Primary endpoint: Airway permeability index (Urinary clearance of mannitol overtime) at 24 hours. Started Oct 2015; status: completed.
02
Drugs
Bronchitol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02306473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02306473.